Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

神经干细胞在中枢神经系统的生长发育中起着至关重要的作用，但随着神经系统疾病的发生，神经细胞的变性死亡是不可避免的。研究表明，移植的神经干细胞可以替代受损的细胞，还可以通过旁分泌作用促进神经组织再生和恢复正常功能。外泌体作为重要的旁分泌介质，不仅在物质 ...

Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic ...

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular ...

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular ...

The POYANG study is evaluating Vabysmo in adult treatment-naive patients with choroidal neovascularization secondary to ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...